|
|
Article: Journal Article Reviews Research Using Oxycyte[R] and PFCs in TBI and Decompression Sickness.
- Article from:
- Blood Weekly
- Article date:
- February 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) announced that an article published by the Journal of Applied Physiology discusses research conducted with Oxycyte[R] in Traumatic Brain Injury (TBI) and decompression sickness. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier (see also Oxygen Biotherapeutics, Inc.).
The article, oPerfluorocarbon Emulsions as a Promising Technology: A Review of Tissue and Vascular Gas Dynamics,o discusses the fundamental knowledge gained regarding how respiratory gas movements are changed when intravenous PFC is present and says that a oparticularly promising area of research is the treatment of gas embolism ...
Related newspaper, magazine, and journal articles:
|
|
Article: Oxygen Biotherapeutics, Inc. Announces Completion ...
PR Newswire;
November 30, 2009 ;
700+ words
... ... commercial goals." About Oxygen Biotherapeutics, Inc. Oxygen Biotherapeutics, Inc. is dedicated ... trauma, wound care, decompression sickness, acute respiratory ... looking statements by Oxygen Biotherapeutics, Inc. referring ...
|
|